Navigation Links
American Biotech Labs(R) Garners 2009 Utah Best of State Award
Date:6/5/2009

    For the second time in three years, the Best of State Program's
    independent judges have recognized American Biotech Labs(R) as Utah's top
    company in the Medical Innovation category

SALT LAKE CITY, UT, June 4 /PRNewswire/ - American Biotech Labs, LLC (ABL), developer of a new class of products based on the company's patented nano-catalytic SilverSol Technology(R), today announced that the company has won the 2009 Utah Best of State award in the category of Medical Innovation. It is the company's second Best of State award in the past three years.

"We are honored that the Best of State judges have chosen to honor ABL with a 2009 Best of State award in the Medical Innovation category," said Dr. William Moeller, a managing director at American Biotech Labs. "This recognition highlights the reality that we are in the midst of a period of tremendous growth, as an increasing number of people throughout the world are beginning to recognize the benefits of ABL's uniquely effective patented silver products."

ABL received its Best of State award May 30 at the 2009 Best of State Awards Gala, a formal dinner event in the Salt Palace Convention Center Ballroom in Salt Lake City. The Best of State program, now in its seventh year, is a multi-faceted recognition program created by award-winning writer, producer and director Mark Layton and 20-year production and management executive Dana Layton to highlight excellence in business, government, education, philanthropy and the arts in Utah.

Winners for the annual Best of State event are chosen for their excellence in a wide variety of endeavors. Candidates are judged based on three criteria: achievement within their field of endeavor (50 percent); innovation or creativity in approach, techniques, methods or processes (30 percent); and contribution to improving the quality of life in Utah (20 percent). Best of State nominees are evaluated by a panel of more than 100 independent judges.

ABL products have received multiple U.S. and international patents and government approvals, including EPA and FDA approval. Most recently, in April 2009, the U.S. Food and Drug Administration (FDA) granted ABL's ASAP Wound Dressing Gel with 510(k) medical device approval "for the topical management of minor cuts, lacerations, abrasions, 1st and 2nd degree burns, and skin irritations." The product utilizes ABL's innovative SilverSol Technology, which has garnered multiple patents in the U.S. and countries throughout the world, including a broad-spectrum use patent for combating many of the world's most destructive pathogens, including malaria, tuberculosis, MRSA and HIV.

ABL has performed extensive anti-microbial studies against bacteria, yeast, fungus and other pathogens. Information about some of these studies is available at the research section of the ABL Website, www.americanbiotechlabs.com/researchprotected/researchmenu.html.

About American Biotech Labs

American Biotech Labs (ABL; www.americanbiotechlabs.com), founded in 1998, utilizes patented processes and SilverSol Technology(R) to create singularly powerful and effective nano-catalytic silver products. In extensive testing performed by a variety of respected laboratories and researchers, ABL's silver hydrosol has consistently demonstrated the ability, without any known toxic side effects, to destroy a wide range of bacteria, viruses, yeast, and molds. ABL products have been approved by the Environmental Protection Agency (EPA) as a disinfectant for dental water lines, and as a surface disinfectant for bacteria, yeast and mold in hospital, residential, commercial and industrial settings; and by the U.S. Food and Drug Administration (FDA) for wound management. The company's products have been the subject of multiple peer-reviewed articles in professional journals, and are sold worldwide at health food stores and by medical professionals under the Silver Biotics(R) and ASAP Solution(R) brands, and through a variety of private labels.


'/>"/>
SOURCE American Biotech Labs, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. VIA Pharmaceuticals DGAT1 Inhibitors Featured in American Diabetes Association Poster Presentation
2. Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings
3. Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service
4. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
5. Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
6. MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States
7. Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions
8. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
9. American Acne & Rosacea Society Announces Acne Awareness Month - June 2009
10. Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association
11. deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):